{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:43:16Z","timestamp":1791193396007,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Swedish National Research Council and European Community","award":["222918"],"award-info":[{"award-number":["222918"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.nbd.2010.05.001","type":"journal-article","created":{"date-parts":[[2010,5,8]],"date-time":"2010-05-08T10:01:51Z","timestamp":1273312911000},"page":"352-361","source":"Crossref","is-referenced-by-count":142,"title":["A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeys"],"prefix":"10.1016","volume":"39","author":[{"given":"Daniella","family":"Rylander","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Iderberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Dekundy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren","family":"Baishen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Danysz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwan","family":"Bezard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Angela","family":"Cenci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2010.05.001_bib1","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.brainres.2004.11.040","article-title":"Protection but maintained dysfunction of nigral dopaminergic nerve cell bodies and striatal dopaminergic terminals in MPTP-lesioned mice after acute treatment with the mGluR5 antagonist MPEP","volume":"1033","author":"Aguirre","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2010.05.001_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2005.09.010","article-title":"Prolonged blockade of NMDA or mGluR5 glutamate receptors reduces nigrostriatal degeneration while inducing selective metabolic changes in the basal ganglia circuitry in a rodent model of Parkinson's disease","volume":"22","author":"Armentero","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2010.05.001_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ana.20296","article-title":"Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia","volume":"57","author":"Aubert","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2010.05.001_bib4","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/jmg.2008.063701","article-title":"A pilot open label, single dose trial of fenobam in adults with fragile X syndrome","volume":"46","author":"Berry-Kravis","year":"2009","journal-title":"J. Med. Genet."},{"issue":"Suppl 4","key":"10.1016\/j.nbd.2010.05.001_bib5","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/S1353-8020(09)70827-2","article-title":"Dopamine receptors and L-dopa-induced dyskinesia","volume":"15","author":"Berthet","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2010.05.001_bib6","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.biopsych.2009.04.005","article-title":"Striatal overexpression of DeltaJunD resets L-DOPA-induced dyskinesia in a primate model of Parkinson disease","volume":"66","author":"Berton","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2010.05.001_bib7","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/35086062","article-title":"Pathophysiology of levodopa-induced dyskinesia: potential for new therapies","volume":"2","author":"Bezard","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2010.05.001_bib8","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.1523\/JNEUROSCI.21-17-06853.2001","article-title":"Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-lesioned macaque model of Parkinson's disease","volume":"21","author":"Bezard","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2010.05.001_bib9","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nm875","article-title":"Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function","volume":"9","author":"Bezard","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2010.05.001_bib10","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.nbd.2004.10.005","article-title":"L-DOPA reverses the MPTP-induced elevation of the arrestin2 and GRK6 expression and enhanced ERK activation in monkey brain","volume":"18","author":"Bezard","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2010.05.001_bib11","doi-asserted-by":"crossref","first-page":"8302","DOI":"10.1523\/JNEUROSCI.23-23-08302.2003","article-title":"Metabotropic glutamate 5 receptor blockade alleviates akinesia by normalizing activity of selective basal-ganglia structures in parkinsonian rats","volume":"23","author":"Breysse","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2010.05.001_bib12","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/0028-3908(95)00077-J","article-title":"Activation of metabotropic glutamate receptors coupled to inositol phospholipid hydrolysis amplifies NMDA-induced neuronal degeneration in cultured cortical cells","volume":"34","author":"Bruno","year":"1995","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2010.05.001_bib13","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1038\/sj.npp.1300540","article-title":"The behavioral profile of the potent and selective mGlu5 receptor antagonist 3-[(2-methyl-1, 3-thiazol-4-yl)ethynyl]pyridine (MTEP) in rodent models of anxiety","volume":"29","author":"Busse","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nbd.2010.05.001_bib14","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tins.2007.03.001","article-title":"Dopamine-mediated regulation of corticostriatal synaptic plasticity","volume":"30","author":"Calabresi","year":"2007","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2010.05.001_bib15","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1111\/j.1471-4159.2006.03696.x","article-title":"Role of striatal L-DOPA in the production of dyskinesia in 6-hydroxydopamine lesioned rats","volume":"96","author":"Carta","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2010.05.001_bib16","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.tins.2007.03.005","article-title":"Dopamine dysregulation of movement control in L-DOPA-induced dyskinesia","volume":"30","author":"Cenci","year":"2007","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2010.05.001_bib17","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.conb.2008.01.004","article-title":"Advances in understanding L-DOPA-induced dyskinesia","volume":"17","author":"Cenci","year":"2007","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.nbd.2010.05.001_bib18","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1471-4159.2006.04124.x","article-title":"Post- versus presynaptic plasticity in L-DOPA-induced dyskinesia","volume":"99","author":"Cenci","year":"2006","journal-title":"J. Neurochem."},{"issue":"Unit 9","key":"10.1016\/j.nbd.2010.05.001_bib19","first-page":"25","article-title":"Ratings of L-DOPA-induced dyskinesia in the unilateral 6-OHDA lesion model of Parkinson's disease in rats and mice","volume":"9","author":"Cenci","year":"2007","journal-title":"Curr. Protoc Neurosci. Chapter"},{"key":"10.1016\/j.nbd.2010.05.001_bib20","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/S1471-1931(00)00018-5","article-title":"Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonism","volume":"23","author":"Chase","year":"2000","journal-title":"Trends Neurosci."},{"issue":"Suppl 2","key":"10.1016\/j.nbd.2010.05.001_bib21","first-page":"II36","article-title":"Antiparkinsonian and antidyskinetic activity of drugs targeting central glutamatergic mechanisms","volume":"247","author":"Chase","year":"2000","journal-title":"J. Neurol."},{"key":"10.1016\/j.nbd.2010.05.001_bib22","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nrn1763","article-title":"Metabotropic glutamate receptors in the basal ganglia motor circuit","volume":"6","author":"Conn","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2010.05.001_bib23","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.brainresbull.2005.12.009","article-title":"Effects of group I metabotropic glutamate receptors blockade in experimental models of Parkinson's disease","volume":"69","author":"Dekundy","year":"2006","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.nbd.2010.05.001_bib24","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/mds.21475","article-title":"Levodopa-induced dyskinesias","volume":"22","author":"Fabbrini","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2010.05.001_bib25","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1474-4422(08)70214-X","article-title":"Non-dopaminergic treatments in development for Parkinson's disease","volume":"7","author":"Fox","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2010.05.001_bib26","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/mds.20936","article-title":"Translation of nondopaminergic treatments for levodopa-induced dyskinesia from MPTP-lesioned nonhuman primates to phase IIa clinical studies: keys to success and roads to failure","volume":"21","author":"Fox","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2010.05.001_bib27","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1523\/JNEUROSCI.5326-05.2006","article-title":"A critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia","volume":"26","author":"Gardoni","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2010.05.001_bib28","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/S0028-3908(99)00082-9","article-title":"2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist","volume":"38","author":"Gasparini","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2010.05.001_bib29","first-page":"43","article-title":"The neostriatal mosaic: multiple levels of compartmental organization","volume":"36","author":"Gerfen","year":"1992","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.nbd.2010.05.001_bib30","doi-asserted-by":"crossref","first-page":"14338","DOI":"10.1523\/JNEUROSCI.4223-07.2007","article-title":"RGS9-2 negatively modulates L-3, 4-dihydroxyphenylalanine-induced dyskinesia in experimental Parkinson's disease","volume":"27","author":"Gold","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2010.05.001_bib31","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.pneurobio.2004.09.005","article-title":"Metabotropic glutamate receptors and striatal synaptic plasticity: implications for neurological diseases","volume":"74","author":"Gubellini","year":"2004","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2010.05.001_bib32","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1460-9568.2005.04196.x","article-title":"Levodopa-induced dyskinesia in MPTP-treated macaques is not dependent on the extent and pattern of nigrostrial lesioning","volume":"22","author":"Guigoni","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2010.05.001_bib33","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.neuropharm.2004.11.008","article-title":"Alterations of striatal NMDA receptor subunits associated with the development of dyskinesia in the MPTP-lesioned primate model of Parkinson's disease","volume":"48","author":"Hallett","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2010.05.001_bib34","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neuropharm.2009.04.011","article-title":"The anxiolytic and analgesic properties of fenobam, a potent mGlu5 receptor antagonist, in relation to the impairment of learning","volume":"57","author":"Jacob","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2010.05.001_bib35","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00213-009-1600-x","article-title":"Effect of the metabotropic glutamate antagonist MPEP on striatal expression of the Homer family proteins in levodopa-treated hemiparkinsonian rats","volume":"206","author":"Jimenez","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.nbd.2010.05.001_bib36","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.nbd.2004.07.005","article-title":"Transcriptome analysis in a rat model of L-DOPA-induced dyskinesia","volume":"17","author":"Konradi","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2010.05.001_bib37","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.nbd.2007.08.011","article-title":"Systemic administration of an mGluR5 antagonist, but not unilateral subthalamic lesion, counteracts l-DOPA-induced dyskinesias in a rodent model of Parkinson's disease","volume":"29","author":"Levandis","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2010.05.001_bib38","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/j.1471-4159.2009.06556.x","article-title":"l-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson's disease: temporal and quantitative relationship to the expression of dyskinesia","volume":"112","author":"Lindgren","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2010.05.001_bib39","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.neuropharm.2006.02.001","article-title":"mGlu1 and mGlu5 receptor antagonists lack anticonvulsant efficacy in rodent models of difficult-to-treat partial epilepsy","volume":"50","author":"Loscher","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2010.05.001_bib40","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.0953-816x.2001.01843.x","article-title":"Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease","volume":"15","author":"Lundblad","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2010.05.001_bib41","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1046\/j.1471-4159.2003.01632.x","article-title":"Cellular and behavioural effects of the adenosine A2a receptor antagonist KW-6002 in a rat model of l-DOPA-induced dyskinesia","volume":"84","author":"Lundblad","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2010.05.001_bib42","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1007\/s11064-008-9654-4","article-title":"Group I metabotropic glutamate receptor-mediated gene expression in striatal neurons","volume":"33","author":"Mao","year":"2008","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.nbd.2010.05.001_bib43","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.eplepsyres.2008.11.004","article-title":"Age-dependent anticonvulsant action of antagonists of group I glutamate metabotropic receptors in rats","volume":"83","author":"Mares","year":"2009","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.nbd.2010.05.001_bib44","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.coph.2005.09.006","article-title":"Glutamate-based therapeutic approaches: allosteric modulators of metabotropic glutamate receptors","volume":"6","author":"Marino","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.nbd.2010.05.001_bib45","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1471-4159.2007.04456.x","article-title":"Antagonism of metabotropic glutamate receptor type 5 attenuates l-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's disease","volume":"101","author":"Mela","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2010.05.001_bib46","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0079-6123(08)60454-9","article-title":"The glutamate synapse as a therapeutical target: perspectives for the future","volume":"116","author":"Meldrum","year":"1998","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.nbd.2010.05.001_bib47","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1749-6632.1995.tb17506.x","article-title":"Roles of metabotropic glutamate receptors in brain plasticity and pathology","volume":"757","author":"Miller","year":"1995","journal-title":"Ann. N Y Acad. Sci."},{"key":"10.1016\/j.nbd.2010.05.001_bib48","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1124\/jpet.109.154138","article-title":"The metabotropic glutamate receptor subtype 5 antagonist fenobam is analgesic and has improved in vivo selectivity compared with the L prototypical antagonist 2-methyl-6-(phenylethynyl)-pyridine","volume":"330","author":"Montana","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2010.05.001_bib49","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.neuropharm.2009.12.024","article-title":"Effect of the metabotropic glutamate receptor type 5 antagonists MPEP and MTEP in parkinsonian monkeys","volume":"58","author":"Morin","year":"2010","journal-title":"Neuropharmacology"},{"issue":"Pt 2","key":"10.1016\/j.nbd.2010.05.001_bib50","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/brain\/119.2.585","article-title":"An [18F]dopa-PET and clinical study of the rate of progression in Parkinson's disease","volume":"119","author":"Morrish","year":"1996","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2010.05.001_bib51","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1093\/brain\/awn235","article-title":"Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia","volume":"131","author":"Munoz","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2010.05.001_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2008.09.013","article-title":"Priming for l-dopa-induced dyskinesia in Parkinson's disease: a feature inherent to the treatment or the disease?","volume":"87","author":"Nadjar","year":"2009","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2010.05.001_bib53","doi-asserted-by":"crossref","unstructured":"Ouattara, B., Gregoire, L., Morissette, M., Gasparini, F., Vranesic, I., Bilbe, G., Johns, D.R., Rajput, A., Hornykiewicz, O., Rajput, A.H., Gomez-Mancilla, B., Di Paolo, T., in press. Metabotropic glutamate receptor type 5 in levodopa-induced motor complications. Neurobiol. Aging doi:10.1016\/j.neurobiolaging.2009.07.014","DOI":"10.1016\/j.neurobiolaging.2009.07.014"},{"key":"10.1016\/j.nbd.2010.05.001_bib54","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00004714-198204000-00010","article-title":"Treatment of anxiety using fenobam (a nonbenzodiazepine) in a double-blind standard (diazepam) placebo-controlled study","volume":"2","author":"Pecknold","year":"1982","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.nbd.2010.05.001_bib55","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nn1040","article-title":"Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia","volume":"6","author":"Picconi","year":"2003","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2010.05.001_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0028-3908(94)00129-G","article-title":"The metabotropic glutamate receptors: structure and functions","volume":"34","author":"Pin","year":"1995","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2010.05.001_bib57","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0306-4522(01)00297-4","article-title":"Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-d-aspartate responses in medium spiny striatal neurons","volume":"106","author":"Pisani","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2010.05.001_bib58","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1124\/jpet.105.089839","article-title":"Fenobam: a clinically validated nonbenzodiazepine anxiolytic is a potent, selective, and noncompetitive mGlu5 receptor antagonist with inverse agonist activity","volume":"315","author":"Porter","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2010.05.001_bib59","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/j.1460-9568.2004.03591.x","article-title":"Chronic L-DOPA treatment increases extracellular glutamate levels and GLT1 expression in the basal ganglia in a rat model of Parkinson's disease","volume":"20","author":"Robelet","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2010.05.001_bib60","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0163-7258(00)00098-X","article-title":"Distribution and roles of metabotropic glutamate receptors in the basal ganglia motor circuit: implications for treatment of Parkinson's disease and related disorders","volume":"88","author":"Rouse","year":"2000","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.nbd.2010.05.001_bib61","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1124\/jpet.108.150425","article-title":"Pharmacological modulation of glutamate transmission in a rat model of L-DOPA-induced dyskinesia: effects on motor behavior and striatal nuclear signaling","volume":"330","author":"Rylander","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2010.05.001_bib62","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.neuropharm.2007.08.009","article-title":"Basal ganglia group II metabotropic glutamate receptors specific binding in non-human primate model of L-Dopa-induced dyskinesias","volume":"54","author":"Samadi","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2010.05.001_bib63","doi-asserted-by":"crossref","first-page":"6995","DOI":"10.1523\/JNEUROSCI.0852-07.2007","article-title":"Critical involvement of cAMP\/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesia","volume":"27","author":"Santini","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2010.05.001_bib64","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/syn.20739","article-title":"Synaptic recruitment of AMPA glutamate receptor subunits in levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate","volume":"64","author":"Silverdale","year":"2010","journal-title":"Synapse"},{"key":"10.1016\/j.nbd.2010.05.001_bib65","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0014-2999(00)00697-X","article-title":"Effects of the prototypical mGlu(5) receptor antagonist 2-methyl-6-(phenylethynyl)-pyridine on rotarod, locomotor activity and rotational responses in unilateral 6-OHDA-lesioned rats","volume":"406","author":"Spooren","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2010.05.001_bib66","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0022-3565(24)39029-9","article-title":"Anxiolytic-like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine in rodents","volume":"295","author":"Spooren","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2010.05.001_bib67","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1523\/JNEUROSCI.14-05-03005.1994","article-title":"Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat","volume":"14","author":"Testa","year":"1994","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2010.05.001_bib68","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1523\/JNEUROSCI.4574-04.2005","article-title":"Metabotropic glutamate receptors and dopamine receptors cooperate to enhance extracellular signal-regulated kinase phosphorylation in striatal neurons","volume":"25","author":"Voulalas","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2010.05.001_bib69","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.biopsych.2006.11.032","article-title":"Spatiotemporal pattern of striatal ERK1\/2 phosphorylation in a rat model of L-DOPA-induced dyskinesia and the role of dopamine D1 receptors","volume":"62","author":"Westin","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2010.05.001_bib70","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.neuroscience.2009.07.060","article-title":"Metabotropic glutamate mGluR5 receptor blockade opposes abnormal involuntary movements and the increases in glutamic acid decarboxylase mRNA levels induced by l-DOPA in striatal neurons of 6-hydroxydopamine-lesioned rats","volume":"163","author":"Yamamoto","year":"2009","journal-title":"Neuroscience"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096999611000152X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096999611000152X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T18:35:15Z","timestamp":1740076515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096999611000152X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":70,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S096999611000152X"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2010.05.001","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}